Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...

A new study from higher education research group Degreechoices found that medical students saw the highest rates of ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

According to a new study published in Psychedelics, the answer ranges from 2.2 to 5.6 million people currently being treated ...

Cybin (Cboe CA:CYBN) has begun its Phase 3 pivotal program, PARADIGM, to evaluate the efficacy and safety of CYB003 as an ...

One study suggests these drugs could increase depression risk in heart attack survivors who retained normal heart pumping ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...

The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...

A tropical depression is likely to form in the next few days from the system currently brewing over the central Caribbean Sea ...

Clearance paves the way for the use of the TMS technology to treat patients with major depressive disorder (MDD), ...

The NHC said Wednesday it is tracking a tropical wave in the Caribbean Sea that could become a tropical depression by the end ...